A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation
Fang Yang, Yiqi Yang, Qiuping Xu, Lin Tang, Yucai Wang, Elizabeth J. Cathcart-Rake, Li Xie · 2026
Read A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation by Fang Yang, Yiqi Yang, Qiuping Xu, Lin Tang, Yucai Wang, Elizabeth J. Cathcart-Rake, Li Xie (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275252.txt.
Description
Fang Yang and co-authors built a risk tool to predict who benefits from chemotherapy in a rare breast cancer in a 2026 population study. Invasive micropapillary carcinoma spreads early to vessels and nodes, yet whether chemotherapy extends life was unproven. Treating everyone alike may harm low risk patients needlessly.
They analyzed 1,150 patients from a national cancer registry covering 2010 to 2018, plus 199 patients from a Chinese hospital for outside validation. Chemotherapy linked to better overall survival, but not clearly to breast cancer specific survival. A model using marital status, tumor size, subtype, and radiation history split patients into high and low risk. Only the high risk group gained survival from chemotherapy, a pattern the outside cohort confirmed. The authors advise careful, selective decisions.
Catalog record
| CREATOR | Fang Yang, Yiqi Yang, Qiuping Xu, Lin Tang, Yucai Wang, Elizabeth J. Cathcart-Rake, Li Xie |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |